PRP IN THE TREATMENT OF TROCHANTERIC SYNDROME: A PILOT STUDY

Overview

Journal Acta Ortop Bras

Specialty Orthopedics

Date 2017 Mar 1

PMID 28243176

Citations 16

Authors

Arthur de Goes Ribeiro

Walter Ricioli Junior

Alice Roxo Nobre Sousa E Silva

Giancarlo Cavalli Polesello

Rodrigo Pereira Guimaraes

Affiliations

Soon will be listed here.

Abstract

Objective: To compare the efficacy of platelet rich plasma (PRP) against corticosteroid on the treatment of trochanteric pain syndrome

Methods: From July 2011 to November 2012, eighteen patients (20 hips) with trochanter pain syndrome were randomized in two groups and treated with platelet rich plasma or triamcinolone infiltration guided by ultrasound. Pain and function were evaluated prior to the intervention and after 10, 30 and 60 days, through the Facial Expressions Scale for Pain and the Western Ontario McMaster and Harris Hip Score questionnaires. Inter-group analysis was performed by Student t-test and intragroup analysis by ANOVA, followed by Bonferroni post hoc test. Statistical significance was set at p <0.05

Results: There was no difference between the groups. The triamcinolone group showed pain reduction (p=0.004) and improved function (p=0.036) through the Harris Hip Score questionnaire at 10, 30 and 60 days after treatment, when compared with the pre- intervention period. The platelet rich plasma group showed no statistical improvement in any of the variables

Conclusion: Up to 60 days, PRP infiltration has no influence on pain relief and function improvement in trochanteric syndrome treatment.

Citing Articles

Assessing Standardisation in Platelet-Rich Plasma (PRP) Injections for the Management of Greater Trochanteric Pain Syndrome (GTPS): A Systematic Review of the Available Literature.

Mahajan U, Papaleontiou A, Imam M, Mahmood A Cureus. 2024; 16(11):e74690.

PMID: 39734950 PMC: 11681989. DOI: 10.7759/cureus.74690.

Current Status and Advancements in Platelet-Rich Plasma Therapy.

Pretorius J, Habash M, Ghobrial B, Alnajjar R, Ellanti P Cureus. 2023; 15(10):e47176.

PMID: 38021947 PMC: 10652151. DOI: 10.7759/cureus.47176.

The 2022 International Society for Hip Preservation (ISHA) physiotherapy agreement on assessment and treatment of greater trochanteric pain syndrome (GTPS): an international consensus statement.

Disantis A, Andrade A, Baillou A, Bonin N, Byrd T, Campbell A J Hip Preserv Surg. 2023; 10(1):48-56.

PMID: 37275836 PMC: 10234389. DOI: 10.1093/jhps/hnac050.

The conservative management for improving Visual Analog Scale (VAS) pain scoring in greater trochanteric pain syndrome: a Bayesian analysis.

He Y, Lin Y, He X, Li C, Lu Q, He J BMC Musculoskelet Disord. 2023; 24(1):423.

PMID: 37237355 PMC: 10214555. DOI: 10.1186/s12891-023-06443-5.

The effect of corticosteroid injection in the treatment of greater trochanter pain syndrome: a systematic review and meta-analysis of randomized controlled trials.

Wang Y, Wang K, Qin Y, Wang S, Tan B, Jia L J Orthop Surg Res. 2022; 17(1):283.

PMID: 35598025 PMC: 9123821. DOI: 10.1186/s13018-022-03175-5.

References

Cohen S, Narvaez J, Lebovits A, Stojanovic M . Corticosteroid injections for trochanteric bursitis: is fluoroscopy necessary? A pilot study. Br J Anaesth. 2004; 94(1):100-6. DOI: 10.1093/bja/aei012. View

Marx R . Platelet-rich plasma (PRP): what is PRP and what is not PRP?. Implant Dent. 2002; 10(4):225-8. DOI: 10.1097/00008505-200110000-00002. View

Mishra A, Woodall Jr J, Vieira A . Treatment of tendon and muscle using platelet-rich plasma. Clin Sports Med. 2008; 28(1):113-25. DOI: 10.1016/j.csm.2008.08.007. View

Filardo G, Kon E, Della Villa S, Vincentelli F, Fornasari P, Marcacci M . Use of platelet-rich plasma for the treatment of refractory jumper's knee. Int Orthop. 2009; 34(6):909-15. PMC: 2989009. DOI: 10.1007/s00264-009-0845-7. View

de Vos R, Weir A, van Schie H, Bierma-Zeinstra S, Verhaar J, Weinans H . Platelet-rich plasma injection for chronic Achilles tendinopathy: a randomized controlled trial. JAMA. 2010; 303(2):144-9. DOI: 10.1001/jama.2009.1986. View

Segal N, Felson D, Torner J, Zhu Y, Curtis J, Niu J . Greater trochanteric pain syndrome: epidemiology and associated factors. Arch Phys Med Rehabil. 2007; 88(8):988-92. PMC: 2907104. DOI: 10.1016/j.apmr.2007.04.014. View

de Vos R, Weir A, Tol J, Verhaar J, Weinans H, van Schie H . No effects of PRP on ultrasonographic tendon structure and neovascularisation in chronic midportion Achilles tendinopathy. Br J Sports Med. 2010; 45(5):387-92. DOI: 10.1136/bjsm.2010.076398. View

de Vos R, van Veldhoven P, Moen M, Weir A, Tol J, Maffulli N . Autologous growth factor injections in chronic tendinopathy: a systematic review. Br Med Bull. 2010; 95:63-77. DOI: 10.1093/bmb/ldq006. View

Peerbooms J, Sluimer J, Bruijn D, Gosens T . Positive effect of an autologous platelet concentrate in lateral epicondylitis in a double-blind randomized controlled trial: platelet-rich plasma versus corticosteroid injection with a 1-year follow-up. Am J Sports Med. 2010; 38(2):255-62. DOI: 10.1177/0363546509355445. View

10.

Moraes V, Lenza M, Tamaoki M, Faloppa F, Belloti J . Platelet-rich therapies for musculoskeletal soft tissue injuries. Cochrane Database Syst Rev. 2013; (12):CD010071. DOI: 10.1002/14651858.CD010071.pub2. View

11.

Little H . Trochanteric bursitis: a common cause of pelvic girdle pain. Can Med Assoc J. 1979; 120(4):456-8. PMC: 1818880. View

12.

Shbeeb M, Matteson E . Trochanteric bursitis (greater trochanter pain syndrome). Mayo Clin Proc. 1996; 71(6):565-9. DOI: 10.4065/71.6.565. View

13.

Kong A, Van der Vliet A, Zadow S . MRI and US of gluteal tendinopathy in greater trochanteric pain syndrome. Eur Radiol. 2006; 17(7):1772-83. DOI: 10.1007/s00330-006-0485-x. View

14.

Sampson S, Gerhardt M, Mandelbaum B . Platelet rich plasma injection grafts for musculoskeletal injuries: a review. Curr Rev Musculoskelet Med. 2009; 1(3-4):165-74. PMC: 2682411. DOI: 10.1007/s12178-008-9032-5. View

15.

Schapira D, Nahir M, Scharf Y . Trochanteric bursitis: a common clinical problem. Arch Phys Med Rehabil. 1986; 67(11):815-7. View

16.

Tirman P, Feller J, McGann W, Prieto V, Wischer T, Cameron J . Tendinosis and tears of gluteus medius and minimus muscles as a cause of hip pain: MR imaging findings. AJR Am J Roentgenol. 1999; 173(4):1123-6. DOI: 10.2214/ajr.173.4.10511191. View

17.

Foster T, Puskas B, Mandelbaum B, Gerhardt M, Rodeo S . Platelet-rich plasma: from basic science to clinical applications. Am J Sports Med. 2009; 37(11):2259-72. DOI: 10.1177/0363546509349921. View

18.

Randelli P, Arrigoni P, Ragone V, Aliprandi A, Cabitza P . Platelet rich plasma in arthroscopic rotator cuff repair: a prospective RCT study, 2-year follow-up. J Shoulder Elbow Surg. 2011; 20(4):518-28. DOI: 10.1016/j.jse.2011.02.008. View

19.

Williams B, Cohen S . Greater trochanteric pain syndrome: a review of anatomy, diagnosis and treatment. Anesth Analg. 2009; 108(5):1662-70. DOI: 10.1213/ane.0b013e31819d6562. View

20.

Taylor D, Petrera M, Hendry M, Theodoropoulos J . A systematic review of the use of platelet-rich plasma in sports medicine as a new treatment for tendon and ligament injuries. Clin J Sport Med. 2011; 21(4):344-52. DOI: 10.1097/JSM.0b013e31821d0f65. View